Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioregenx (BRGX) Non Operating Income (2023 - 2024)

Bioregenx has reported Non Operating Income over the past 2 years, most recently at -$67553.0 for Q3 2024.

  • For Q3 2024, Non Operating Income fell 33.82% year-over-year to -$67553.0; the TTM value through Sep 2024 reached -$522359.0, down 257.64%, while the annual FY2023 figure was -$461508.0, N/A changed from the prior year.
  • Non Operating Income for Q3 2024 was -$67553.0 at Bioregenx, down from -$66331.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at -$45732.0 in Q1 2023 and troughed at -$315453.0 in Q4 2023.